Advertisement
Research Article| Volume 1, ISSUE 3, P439-450, September 1981

Organization of a Laboratory Service for Therapeutic Drug Monitoring

  • Martha I. Walters
    Correspondence
    Corresponding author: Department of Pathology, The Ohio State University, 410 W. 10th Street, Columbus, Ohio 43210
    Affiliations
    Assistant Professor, Department of Pathology, The Ohio State University College of Medicine; Director, Therapeutic Drug Monitoring Laboratory, Ohio State University Hospitals, Columbus, Ohio
    Search for articles by this author
  • Carl E. Speicher
    Affiliations
    Professor, Department of Pathology, The Ohio State University College of Medicine; Director, Clinical Laboratories, Ohio State University Hospitals, Columbus, Ohio
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)31083-7
Organization of a Laboratory Service for Therapeutic Drug Monitoring
Previous ArticleForeword
Next ArticleInstrumentation and Techniques For Therapeutic Drug Monitoring
      This paper is only available as a PDF. To read, Please Download here.
      A laboratory service for therapeutic drug monitoring is designed to measure plasma drug levels in order to achieve optimal therapeutic effect and to avoid toxic effect. After deciding which drugs should be measured, equipment, supply, personnel, and space requirements must be considered. The careful design of the request form and an ongoing quality control program are other critical factors in the successful organization and continuation of a laboratory service.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

      1. Accreditation Manual for Hospitals. Chicago, Illinois, Joint Commission on Accreditation of Hospitals, 1980.

      2. Check Sample Program. Chicago, Illinois, Commission on Continuing Education, American Society of Clinical Pathologists, 1981.

      3. Clinical Laboratories Improvement Act of 1967 (CLIA). 42 U.S.C., 263a.

      4. Commission on Laboratory Inspection and Accreditation. Skokie, Illinois, College of American Pathologists, 1981.

        • Dito W.R.
        Therapeutic drug monitoring in your laboratory.
        Diagn. Med. 1980; 3: 21-25
        • Henry J.B.
        • Murphy J.
        Effective utilization of clinical laboratories.
        in: Henry J.B. Clinical Diagnosis and Management by Laboratory Methods. W. B. Saunders Co., Philadelphia1979: 2039-2048
        • Juel R.
        Quality control in therapeutic drug monitoring.
        Lab. Med. 1980; 11: 788-795
        • Lundberg G.D.
        Critical (panic) values revisited.
        Med. Lab. Observer. 1977; 9: 27-34

      9. Quality Assurance Service Committee. Skokie, Illinois, College of American Pathologists, 1981.

        • Speicher C.E.
        Survey of Request Forms and Report Forms in Therapeutic Drug Monitoring and Toxicology.
        Technical Bulletin of The Ohio State University, Columbus, Ohio1980
        • Speicher C.E.
        • Smith J.W.
        Interpretive reporting in clinical pathology.
        J.A.M.A. 1980; 243: 1556-1560
        • Svirbely J.R.
        • Speicher C.E.
        The importance of request and report forms in the interpretation of therapeutic drug monitoring data.
        Ther. Drug Monitor. 1981; 2: 211-216

      13. Therapeutic Monitoring Program. Atlanta, Georgia, Center for Disease Control, 1981.

      14. Therapeutic Drug Monitoring Continuing Education and Quality Control Program. Washington, D.C., American Association for Clinical Chemistry, 1981.

      15. Workload Recording Committee. Skokie, Illinois, College of American Pathologists, 1981.

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)31083-7

      Copyright

      © 1981 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX